 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 1998, 18(7):2653-2666
Differential Modulation of High-Frequency
-Electroencephalogram Activity and Sleep-Wake State by
Noradrenaline and Serotonin Microinjections into the Region of
Cholinergic Basalis Neurons
Edmund G.
Cape and
Barbara E.
Jones
Department of Neurology and Neurosurgery, McGill University,
Montréal Neurological Institute, Montréal, Québec
H3A 2B4, Canada
 |
ABSTRACT |
Several lines of evidence indicate that cholinergic basalis neurons
play an important role in cortical activation. The present study was
undertaken to determine the effect of noradrenergic and serotonergic
modulation of the cholinergic neurons on cortical EEG activity and
sleep-wake states. The neurotransmitters were injected into the region
of the basalis neurons by remote control in freely moving, naturally
sleeping-waking rats during the day when the rats are normally asleep
the majority of the time. Effects were observed on behavior and EEG
activity, including high-frequency activity (30-60 Hz), which has
been demonstrated to reflect behavioral and cortical arousal in the
rat. Noradrenaline, which has been shown in previous in
vitro studies to depolarize and excite the cholinergic cells,
produced a dose-dependent increase in -EEG activity, a decrease in
activity, and an increase in waking. Serotonin, which has been
found in previous in vitro studies to hyperpolarize the
cholinergic neurons, produced a dose-dependent decrease in -EEG
activity with no significant change in amounts of wake or slow wave
sleep. Both chemicals resulted in a dose-dependent decrease in
paradoxical sleep.
These results demonstrate that noradrenaline and serotonin exert
differential modulatory effects on EEG activity through the basal
forebrain, the one facilitating activity and eliciting waking and
the other diminishing activity and not significantly affecting slow
wave sleep. The results also confirm that the cholinergic basalis
neurons play an important role in cortical activation and particularly
in the high-frequency activity that underlies cortical and
behavioral arousal of the wake state.
Key words:
waking; slow wave sleep; paradoxical sleep; locus
coeruleus; raphe; basal forebrain; acetylcholine
 |
INTRODUCTION |
Early studies, which investigated
the effects of pharmacological manipulation of cholinergic transmission
or examined the release of acetylcholine (ACh) from the cerebral cortex
across sleep-wake states, clearly indicated that cholinergic neurons play an important role in cortical activation that occurs during the
states of wake and paradoxical sleep (Celesia and Jasper, 1966 ; Longo,
1966 ; Jasper and Tessier, 1971 ) (for review, see Jones, 1993 ). The
neurons that provide the major cholinergic innervation to the cerebral
cortex are located in the nucleus basalis of Meynert (Shute and Lewis,
1967 ; Lehmann et al., 1980 ; Rye et al., 1984 ). Lesions of the basal
forebrain cholinergic cells are associated with a decrease in cortical
ACh release and a parallel decrease in cortical activation (Lo Conte et
al., 1982 ; Stewart et al., 1984 ; Buzsáki et al., 1988 ).
Reciprocally, electrical or chemical stimulation of the cholinergic
basalis neurons in anesthetized or brainstem-transected animals leads
to a parallel increase in cortical ACh release and cortical activation
(Casamenti et al., 1986 ; Rasmusson et al., 1994 ). In the present study
we examined the effects of chemical stimulation in naturally
sleeping-waking rats on sleep-wake state and EEG activity, focusing
on high-frequency activity (30-60 Hz), which we have shown to be
indicative of behavioral and cortical arousal in the rat (Maloney et
al., 1997 ).
Cholinergic basal forebrain neurons lie in the path of the major
ascending fiber system from the brainstem reticular activating system
and thus serve as the ventral extrathalamic relay to the cerebral
cortex (Moruzzi and Magoun, 1949 ; Starzl et al., 1951 ). The brainstem
neurons projecting into the region of the cholinergic basalis neurons
are composed of monoaminergic neurons in addition to putative
glutamatergic neurons of the reticular formation (for review, see
Jones, 1995 ). Thus, noradrenergic locus coeruleus and serotonergic
raphe neurons project into the basal forebrain in addition to
projecting directly to the cerebral cortex (Semba et al., 1988 ; Jones
and Cuello, 1989 ; Jones, 1995 ). More recently, by intracellular
recording and labeling in vitro, identified cholinergic basalis neurons were shown to be innervated by noradrenergic and serotonergic fibers and to be modulated in different ways by these two
neurotransmitters (Khateb et al., 1992 , 1993 ; Fort et al., 1995 ).
Noradrenaline was found to depolarize and excite, whereas serotonin
(5-hydroxytryptamine; 5-HT) was found to hyperpolarize and inhibit the
cholinergic cells. The significance or role of this modulation in
vivo, however, remains to be determined. The aim of the present
study thus was to examine the effects of microinjections of
noradrenaline and serotonin into the region of the cholinergic basalis
neurons on cortical EEG activity and sleep-wake state in freely
moving, naturally sleeping-waking animals. This was accomplished by
developing a microinjection procedure that allowed remote control for
the lowering of the filled cannulae and injection of the chemicals. The
results show different effects of noradrenaline and serotonin on
-EEG activity and sleep-wake states.
Preliminary results of this study were reported previously (Cape and
Jones, 1994 ).
 |
MATERIALS AND METHODS |
Animals and surgery. A total of 24 male Wistar rats
(Charles River Canada, Montréal, Canada), weighing between 200 and 250 gm at the time of surgery, were used in this study. Nine
animals were used for pilot studies, and 15 were used for experimental studies. For implantation of electrodes and cannulae, animals were
anesthetized with barbiturate anesthesia (Somnotol, 67 mg/kg, i.p.) and
placed in the stereotaxic instrument with the tooth bar set at 0.33
mm. For EEG recording, jeweller's screws (1 mm diameter at exposed tip
and 3 mm in length) were threaded into burr holes in the skull to come
into minimal contact with the dura. They were placed bilaterally by
reference to Bregma over frontal (2.7-3.0 mm anterior, 0.6 mm
lateral), retrosplenial (3.5 mm posterior, 0.6 mm lateral), parietal
(0.5 mm posterior, 5.0 mm lateral), and occipital (7.5 mm posterior,
5.0 mm lateral) cortical regions. A reference electrode was cemented in
bone rostral to the frontal cortex and caudal to the olfactory bulbs
(5.5 mm anterior, 0.6 mm lateral). EMG was recorded by means of two
stainless steel wires inserted in the neck musculature. A ground
electrode was implanted over the cerebellum (~1 mm posterior to
lambda and 2 mm from the midline). The electrodes were joined to a
small female connector.
For microinjections, stainless-steel cannulae (Plastics One, Roanoke,
VA) were used and included guide cannulae (26 gauge, 0.46 mm outer
diameter) with fitted dummy stylets and internal cannulae (33 gauge,
0.20 mm outer diameter). The guide cannulae were placed bilaterally
such that when the internal cannulae were lowered 2.0 mm below the tip
of the guides, they reached the target site in the basal forebrain
[using anterior-posterior (AP), lateral (L), and vertical (V)
coordinates with reference to ear bar zero: AP +7.7 mm, L 2.5 mm, and V
+1.5 mm] (see Fig. 1). The guide cannulae were implanted and
maintained with dummy stylets that extended beyond the guides by 0.5 mm. The guide cannulae and electrodes were fixed to the skull with
dental cement.
After a minimum of 2 d recovery after surgery, each rat was housed
individually in a Plexiglas box inside a large electrically shielded
recording chamber in which they were maintained on a 12:12 light-dark
cycle (lights on from 7:00 A.M. to 7:00 P.M.). They had free access to
rat chow and water. For the duration of the experiment, the connector
on the rat's head was attached to a cable connected to a commutator
that was suspended with a balanced boom to allow free movement of the
animal in the chamber. Baseline recording was initiated after a minimum
of 2 d habituation to the chamber and cable.
At the end of the experiments, the animals were killed under
barbiturate anesthesia (Somnotol, ~120 mg/kg). Most (20 of 24) were
perfused through the heart with a fixative solution [3.0% paraformaldehyde, as published previously (Gritti et al., 1993 )]. The
brains were frozen and subsequently were processed for histology and
choline acetyltransferase immunohistochemistry (Gritti et al., 1993 ) so
that the placement of the cannulae could be examined.
EEG recording and behavioral observations. The EEG and EMG
signals were recorded with a Grass model 78D polygraph. All signals were filtered between 1.0 and 100 Hz. The EEG signals were recorded with a gain that was adjusted to be the same on each channel and to
remain the same for the duration of the study. The amplifier output was
sent to an IBM compatible computer running Stellate Systems software
(Montréal, Québec, Canada) for on-line analog-to-digital (A/D) conversion and off-line analysis of EEG. The signals were sampled
at a rate of 512 Hz and filtered with a Finite Impulse Response (FIR)
filter with a cut-off frequency at 128 Hz. The data were stored at a
sampling rate of 256 Hz.
The rat's behavior was observed with the aid of a video monitor and
marked on-line by annotations on the computer record. Behavioral
annotations included the following in the order in which they
frequently occur during a normal sleep-wake cycle in association with
a waking (W) or sleep (S) posture: Wattentive (when the
animal was immobile and seemingly attending to a stimulus), Wmoving (including walking), Weating,
Wgrooming, Wquiet (when the animal was lying down
but with eyes open), Suncurled (outstretched with eyes
closed), Scurled (curled up with eyes closed),
Smoving (adjusting posture with eyes closed), and
Stwitch (showing rapid movements of eyes, ears, or whiskers
while asleep with eyes closed) (Maloney et al., 1997 ).
Recording was performed beginning in the late morning and usually
ending by 3:00 P.M. in the afternoon. The EEG computer file consisted
of a morning recording period (~11:00 A.M.-11:30 A.M., taken before
handling) and an afternoon recording period (~12:30 P.M.-3:00 P.M.,
taken after handling and the placement of the inner cannulae for
microinjections). The afternoon recording was not begun until the
animal had recovered from the handling, as evidenced behaviorally by
the resumption of sleep. For baseline recording that was performed
before any injections, the animal was picked up and handled during the
time that the injection cannulae would be inserted.
Injection procedure. Ringer's and chemical injections
proceeded in several stages (see Fig. 1A). After the
30 min morning recording (defined as the preinjection period), the
animal was picked up for removal of the stylets and manual placement of
the filled internal cannulae. The filled cannulae were inserted into the guide cannulae and held there in a position ~2 mm above the tissue (i.e., ~4 mm dorsal to their eventual target; Fig.
1A) to avoid premature contact of the chemical
solution with the brain. After the rat's recovery from the handling
procedure, evidenced behaviorally by the apparent resumption of sleep,
the afternoon recording session was begun. After the appearance of a
full sleep cycle, evidenced on the EEG by the passage through slow wave
sleep into transition into paradoxical sleep (tPS) or PS
(usually over a ~30 min period), the filled inner cannulae were
lowered into the brain. This was accomplished without disturbing the
rat by use of a remotely controlled mechanism consisting of inner
tubing connected to the inner cannula that slid within outer tubing
connected to the cap of the outer cannula on the rat's head. From
outside the cage, the inner tubing was slid forward to a point
determined by the fitting of the hub of the inner cannulae into the cap
of the outer cannula, which corresponds to the point of full descent of
the inner cannula into the brain. The left and right cannulae were
lowered in sequence. The injections subsequently were begun ~2 min
after the cannulae came into contact with the brain tissue. They were
made bilaterally with a syringe pump (Sage Instruments, Cambridge, MA)
that simultaneously advanced both syringe plungers over a period of
~5 min. The postinjection condition was defined for statistical
analysis as the 30 min period immediately after the injection and was
based on the period during which the chemicals would diffuse
maximally within the restricted radius of the injection site (Martin,
1991 ). Recording nonetheless was continued for at least 60 min after
the injection, after which the inner cannulae and tubes were removed
from the brain and head of the animal.
Chemical microinjections. Chemicals were delivered via two 1 µl Hamilton syringes (Reno, NV) simultaneously driven by a syringe pump (model 341 A, Sage Instruments, Orion Research, Cambridge, MA).
Connected to the syringes, polyethylene tubing (~50 cm) was filled
with paraffin oil up to the last ~1 cm (or ~1.5 µl) of each inner
cannula, which was filled with the chemical solution. The chemicals
were dissolved in buffered Ringer's containing (in mM)
156.14 NaCl, 3.35 KCl, 2.70 CaCl2, and 2.38 NaHCO3.
All solutions were injected in volumes of 0.5 µl (at a rate of ~0.1
µl/min) that, on the basis of previous injections of neuroanatomical tracers into the basal forebrain (Jones and Yang, 1985 ; Jones and
Beaudet, 1987 ), was estimated to diffuse from the tip of the cannula in
a radius of up to 1 mm around the tip and >1 mm along the shaft of the
cannulae (see Fig. 1). Initial doses and/or concentrations of
noradrenaline and serotonin were based on those used in published studies and aimed at reaching adequate concentrations at
neurotransmitter receptors over a wide area (Myers, 1974 ; Wenk, 1984 ).
In pilot studies, noradrenaline (L-arterenol bitartrate;
Sigma, St. Louis, MO) was injected at doses of 600, 250, 75, 50, and 25 nmol, all of which produced an awakening and arousal of differing
intensities and durations. A dose of 75 nmol of noradrenaline (15 µg
in a 0.5 µl total dose per side, corresponding to a concentration of 150 mM) was selected for a consistent, robust effect and
administered to eight rats. Serotonin (5-hydroxytryptamine creatine
sulfate, 5-HT; Sigma) was injected at doses of 1000, 500, 250, 125, and 62.5 nmol, none of which produced an awakening; instead, all appeared to produce a change in EEG activity that was apparent during diurnal sleep at the higher doses. A dose of 250 nmol of serotonin (53.2 µg
in a 0.5 µl total dose per side, corresponding to a concentration of
500 mM) was selected for a consistent, robust effect and
administered to 11 animals. In eight animals receiving both 5-HT and
noradrenaline, the two drugs were administered in random order, with at
least 48 hr between drug administrations.
Subsequently, another series of experiments was conducted in five rats
to establish if the effects observed were dose-dependent. In addition
to Ringer's, four doses of each drug were administered, with the dose
used in the main study as the maximum dose. For noradrenaline, the low
dose was established as that producing a lesser but apparent effect,
and the range represented doses at 100, 67, 50, and 33% of the dose
used in the main study. For serotonin, the drug was administered at
doses representing 100, 50, 25, and 12.5% of the dose used in the main
study to include doses overlapping with those of noradrenaline. In
these animals the order in which noradrenaline and serotonin were
administered was varied across rats, and the interval separating the
two drug administrations was at least 48 hr.
Data analysis. The EEG was examined by off-line analysis on
a computer screen and scored by visual assessment according to sleep-wake states in 20 sec epochs. State was classified as one of
five states: (1) wake, (2) transition into slow wave sleep (tSWS), (3) slow wave sleep (SWS), (4) transition
into paradoxical sleep (tPS), and (5) paradoxical sleep (PS)
(Maloney et al., 1997 ). Particularly during the postinjection
condition, the state of the rat also was assessed by consideration of
the behavioral annotations in addition to the EEG and EMG activities.
Consequently, the annotations were used to identify any dissociations
between behavior and the normally associated EEG patterns of the
different states (Maloney et al., 1997 ). Each state was
reported for the postinjection recording period as a percentage of
total recording time.
Spectra were computed by using Stellate Systems software by Fast
Fourier Transform (FFT), which was based on 512 points corresponding to
2 sec epochs, with a resolution of 0.5 Hz. A seven-point smoothing window was applied by this program, thus allowing a minimum of 1.5 Hz
and a maximum 63.5 Hz in the spectral computation. Frequency bands were
set at the following ranges: for , 1.5-4.0 Hz; for , 4.5-8.5
Hz; for , 9.0-14.0 Hz; for 1, 14.5-18.5 Hz; for 2, 19.0-30.0 Hz; and for , 30.5-58.0 Hz (eliminating frequencies at
~60 Hz to avoid any possible contamination from AC noise) (Maloney et
al., 1997 ). Total activity within each band was calculated automatically for 20 sec recording epochs that were scored for sleep-wake state. Based on the scored records, sleep-wake hypnograms were displayed in association with EEG frequency band activities from
the right retrosplenial lead for 20 sec epochs over the recording sessions with Eclipse software (Stellate Systems). Spectral analysis also was performed with Rhythm software (Stellate Systems) on 4 sec
epoch samples (n = 5 per rat), which were selected for
uniformity as well as representativeness of EEG activity, at 1 min
intervals ~2-8 min postinjection. Spectrum and frequency band
activities were displayed and reported in A/D amplitude units for which
the average gain was calibrated as ~1500 A/D units per millivolt on the EEG channels. Relative amplitudes of each band also were reported and correspond to the percentage of total activity (1.5-58.0 Hz). The
ratio of / (Th/De) was calculated and reported as a reflection of
regular activity in the EEG (Maloney et al., 1997 ). EMG amplitude was computed for the total spectrum up to 58.0 Hz.
EEG records and hypnograms displaying sleep-wake state and frequency
band activity were examined after recording to establish, first, a
normal EEG and, second, an effective microinjection. Data were excluded
from analysis if any signs of abnormal EEG activity were evident as
indicative of seizure-like activity common to rodents (Vergnes et al.,
1982 ). Of 15 rats, three had to be eliminated for this reason, and data
points were eliminated in two other rats because of the presence of
abnormal activity after noradrenaline. One rat was eliminated because
of an apparent failure of the drugs to be delivered consistently, which
was interpreted as attributable to clogging of the cannulae.
Statistical comparisons were performed for the average percentage
sleep-wake state and for EEG and EMG activity. For EEG activity, statistics were presented from the right retrosplenial cortical lead
for and activity and for Th/De ratio, which were shown previously to reflect maximally the behavioral and state changes in the
rat (Maloney et al., 1997 ). Comparisons were made first between
post-Ringer's and baseline conditions (in eight rats, by paired
t tests) to determine whether the Ringer's microinjections were associated with any significant changes in EEG, behavior, or
sleep-wake states. Comparisons subsequently were made between post-noradrenaline (in five rats) or post-serotonin (in eight rats, of
which five also received noradrenaline) and post-Ringer's conditions
by paired comparisons (using Student's t tests) for individual animals, involving one trial per condition per animal. For
analysis of the dose-response relationships, an analysis of covariance
(ANCOVA) was used, with dose as the main factor (df = 4) and
subject as a covariate (df = 1), involving four rats for
noradrenaline and three overlapping rats for serotonin (with a total of
31 data points). All statistics were performed with Systat software
(Evanston, IL).
 |
RESULTS |
In histology, tracks of the injection cannulae were evident
passing through the caudate putamen and globus pallidus into the substantia innominata [at the border between the anterior (SIa) and
posterior (SIp) sectors] and above the magnocellular preoptic nucleus,
where the cholinergic cell bodies are located (Fig.
1B). They were
bilaterally symmetric in all animals.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 1.
A, Schematic drawing of the rat
brain (in sagittal view) illustrating chemical microinjections into the
region of cholinergic basalis neurons (open circles),
which are known to project to the cerebral cortex (dashed
lines) and to receive input from noradrenergic and serotonergic
afferents (solid lines), respectively, arriving from the
dorsal raphe (DR) and locus coeruleus
(LC) nuclei in the brainstem [adapted with permission
from Jones (1995) ]. Bilateral microinjections of Ringer's,
noradrenaline, or serotonin were performed by insertion of inner
injection cannulae into chronically indwelling guide cannulae. The
cannulae are drawn according to the coordinates used for implantation
and the histological verification of their position. At the time of the experiment, inner cannulae, which were filled with the chemical for injection, were inserted first
within the guide cannulae (to within ~2 mm of tip, marked by
arrow), where they were held until the time of
injection. Immediately before injection, the inner cannulae on both
sides were lowered by a remote driving mechanism (~4 mm) to pass out
of the guide cannulae, through the globus pallidus (GP),
into the substantia innominata (SI; to ~2 mm below the
guide cannulae, marked by lower arrow), and above the
magnocellular preoptic nucleus (MCPO). The diffusion of
the chemical solution is depicted according to estimates that are based
on previous injections of the same volume (0.5 µl) of neuroanatomical
tracers into the basal forebrain (Jones and Yang, 1985 ; Jones and
Beaudet, 1987 ). B, Drawing of coronal section through
the middle of the injection site showing approximate placement of
cannulae, based on the location of tracks, in relationship to
ChAT-immunostained cells (mapped with the aid of an image analysis system). ac, Anterior commissure; AV,
anteroventral thalamic nucleus; CL, centrolateral
thalamic nucleus; CPu, caudate putamen;
DpMe, deep mesencephalic reticular field;
FF, fields of Forel; Gi, gigantocellular reticular field; GiA, gigantocellular reticular
field, part; GiV, gigantocellular reticular field,
ventral part; GP, globus pallidus; ic,
internal capsule; LC, locus coeruleus;
LD, laterodorsal thalamic nucleus; LH,
lateral hypothalamic area; LP, lateral posterior thalamic nucleus; MCPO, magnocellular preoptic nucleus;
oc, optic chiasm; opt, optic tract;
OTuD, olfactory tubercle, deep layer; PC,
paracentral thalamic nucleus; PF, parafascicular
thalamic nucleus; PnC, pontine reticular field, caudal
part; PnO, pontine reticular field, oral part;
PnV, pontine reticular field, ventral part;
PPTg, pedunculopontine tegmental nucleus;
R, red nucleus; RRF, retrorubral field;
Rt, reticular thalamic nucleus; SIa,
substantia innominata, anterior part; SIp, substantia
innominata, posterior part; SN, substantia nigra;
st, stria terminalis; VL, ventrolateral thalamic nucleus; VM, ventromedial thalamic nucleus;
VTA, ventral tegmental area; ZI, zona
incerta.
|
|
Baseline
During baseline recording periods, rats manifested brief waking
episodes with alternating more prolonged periods of sleep. During the
30 min recording period of the afternoon (generally occurring between
~1:00 P.M. and 2:00 P.M.), they all passed through at least one
complete sleep cycle, as marked by the appearance of tPS and
PS after tSWS and SWS (n = 8; Fig.
2). The alternation of waking and
sleeping and the full cycle passing from wake through tSWS-SWS into tPS-PS were associated with
differential changes in EEG frequency bands (Fig. 2). As shown
previously (Maloney et al., 1997 ), activity was high during
attentive and active periods of wake, often marked by increases in EMG
activity, and during PS periods, which were characterized by low EMG
activity. increased in the transition into SWS (tSWS)
and was high during SWS. The ratio of Th/De, which reflects EEG
rhythmic slow activity in the range (Maloney et al., 1997 ),
appeared to vary in parallel with .

View larger version (30K):
[in this window]
[in a new window]
|
Figure 2.
Hypnogram (top) and EEG and EMG
frequency band activities (bottom) per 20 sec epoch
during morning (left) and afternoon
(right) recording periods (rat B10). For EEG, (Ga, 30.5-58.0 Hz) and (De, 1.5-4
Hz) absolute activities and / ratio (Th, 4.5-8.5 Hz/De, 1.5-4 Hz) from right retrosplenial cortex are
displayed. Recording was begun in the morning (~11:00 A.M. = 0) and
continued for ~30 min before the animal was handled for mock
insertion of injection cannulae (during the break marked by
dividing line). After relaxation and resumption of sleep
(usually in ~30-45 min), recording was begun again for the
afternoon. In this baseline record, 0 marks the
approximate time at which an injection would have been performed and
thus defines the 30 min baseline period with which the Ringer's
postinjection period was compared (see Fig. 4). In this undisturbed
period during baseline recording, the rat is asleep the majority of the
time. is highest in association with brief periods of active wake
(with high EMG activity) and with PS (with low EMG activity) and lowest
in association with SWS. varies in a reciprocal manner, high in
association with SWS and low during both wake and PS. The Th/De ratio
is high during brief periods of active wake and highest during PS.
Ga, De, and EMG frequency
band activities are displayed as amplitude units scaled to maximum
activity. In this figure, the maximum amplitude for Ga
is 157, for De is 417, and for EMG is 630 (A/D units, in which 100 units 79 µV); the maximum ratio of
Th/De is 2.4. Time lines indicate the baseline periods
corresponding to 30 min pre- and postinjection recording periods.
PS, Paradoxical sleep; SWS, slow wave
sleep; tPS, transition into paradoxical sleep;
tSWS, transition into slow wave sleep.
|
|
During the 30 min afternoon recording period in the baseline condition,
which would correspond approximately to the postinjection period in the
experimental condition, the rats were asleep, on average, the majority
of the time (>70%; Fig. 3). They spent
~55% of the time in tSWS and SWS and >15% in
tPS and PS. varied significantly as a function of state
and was higher during wake and tPS and PS than during
tSWS and SWS; varied significantly in a reciprocal manner to across these states (as examined by repeated measures ANOVA, df = 4, 24; p 0.05). Th/De also varied
significantly as a function of state and, like , was highest in wake
and PS, although much higher on average in PS than in wake.

View larger version (11K):
[in this window]
[in a new window]
|
Figure 3.
Average percentage of state and EEG and EMG
activities from baseline recording during the 30 min afternoon
(equivalent postinjection) recording period (see Fig. 2), demonstrating
the amounts of each state and the associated changes in EEG and EMG
activities. The % State reflects the relative amounts
of time spent in each state; Ga and De
are frequency band activities, Th/De is the ratio of band activities, and EMG is the total spectral activity
across sleep-wake states (EEG activities are taken from the right
retrosplenial lead and are reported together with EMG as amplitude in
A/D units, in which 100 units 79 µV, or are reported as a
ratio). Data are presented as mean ± SEM for eight rats.
Ga, De, Th/De, and EMG all varied significantly as a function of state
(repeated measures ANOVA with df = 4, 24; p 0.05).
|
|
Microinjections
Whereas microinjections of Ringer's solution did not appear to
alter the sleep-wake states or EEG activities of the rats (Fig. 4), microinjections of noradrenaline
(Fig. 5) and serotonin (Fig. 6) appeared to alter these in different
ways (Figs. 7-10).

View larger version (33K):
[in this window]
[in a new window]
|
Figure 4.
Hypnogram and EEG and EMG activities (per 20 sec
epoch) during Ringer's pre- and postinjection recording periods (rat
B10). After the preinjection recording period, the filled inner
cannulae were inserted in the guide cannulae (see Fig. 1), and the
animal was allowed to resume sleeping before recording was reinitiated. With the appearance of a normal sleep cycle, marked by SWS and tPS, leading to PS, the cannulae were lowered via remote
control into the basal forebrain (see Fig. 1); the bilateral injection was started ~2 min later and was performed over ~5 min. The
postinjection recording period was defined as the 30 min period after
the injection was stopped (time, 0-30 min at right).
Note the minimal disturbance to the sleep-wake cycle caused by the
injection procedure and the injection of Ringer's. EEG frequency band
activity is from the right retrosplenial lead and, together with EMG,
is displayed as amplitude units or as a ratio scaled to maximum
activity. In this figure, the maximum amplitude for Ga
is 180, for De is 360, and for EMG is 475 (A/D units, in which 100 units 79 µV); the maximum
Th/De ratio is 2.2.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Figure 5.
Hypnogram and EEG and EMG activities (per 20 sec
epoch) during noradrenaline pre- and postinjection recording periods
(rat B10). Note the immediate occurrence of wake once the filled
cannulae are inserted and the maintenance of a wake state in
association with moderately high -EEG activity and low -EEG
activity during the entire postinjection period. Both
Th/De and EMG remain relatively high. EEG
frequency band activity is from the right retrosplenial lead and,
together with EMG, is displayed as amplitude units or as a ratio scaled
to maximum activity. In this figure, the maximum amplitude for
Ga is 155, for De is 395, and for
EMG is 550 (A/D units, in which 100 units 79 µV); the maximum Th/De ratio is 2.3.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Figure 6.
Hypnogram and EEG and EMG activities (per 20 sec
epoch) during serotonin pre- and postinjection recording periods (rat
B20). Note the continuity of SWS during and after the injection in
association with a decrease in activity and the persistence of activity. No PS occurs in the postinjection period, and
Th/De ratio remains low. Moderate EMG activity is
present. The EEG frequency band activity is from the right
retrosplenial lead and, together with EMG, is displayed as amplitude
units or as a ratio scaled to maximum activity. In this figure, the
maximum amplitude for Ga is 156, for De
is 380, and for EMG is 800 (A/D units, in which 100 units 79 µV); the maximum Th/De ratio is
3.6.
|
|

View larger version (8K):
[in this window]
[in a new window]
|
Figure 7.
Percentage of time spent in sleep-wake states
during Ringer's (R), noradrenaline
(NA), and serotonin (5-HT)
postinjection periods. Values are mean ± SEM for
R, n = 8; for NA,
n = 5; and for 5-HT,
n = 8. *Significantly different from Ringer's,
according to paired comparison t tests
(p 0.05).
|
|
Ringer's solution
Most animals were awakened briefly when the
injection cannulae were lowered into the basal forebrain, but all
resumed sleeping before or during injections with Ringer's solution
(n = 8; see Fig. 4). After the injection was stopped,
all rats experienced some epochs of SWS within the first 5 min. In the
30 min postinjection period, all animals showed an alternation of wake
and SWS and a progression through SWS to tPS-PS or
tPS. During these state changes, the EEG frequency band
activities varied in association with state and behavior in a manner
that was not distinguishable from that in the preinjection period or
that in the baseline postinjection recording period.
As compared with the baseline afternoon recording period, there
were no significant changes in the average relative amounts of
sleep-wake states after Ringer's injections (as examined in eight
rats with paired comparison t tests). The rats were still asleep the majority of the time (>80%) and spent >65% of time in
tSWS and SWS and ~15% in tPS and PS (Fig. 7),
although the percentage of PS was insignificantly lower than that in
baseline. Similarly, the average and activities were not
different after Ringer's (Fig. 8), as
compared with baseline over the 30 min afternoon or postinjection
period or in any of the sleep-wake states during that period. There
was a significant change in Th/De ratio, being lower during the
postinjection period after Ringer's.

View larger version (9K):
[in this window]
[in a new window]
|
Figure 8.
Average EEG and EMG activities during
postinjection recording periods after Ringer's
(R), noradrenaline (NA), and
serotonin (5-HT) microinjections. For EEG (from
right retrosplenial lead), Ga and De are
expressed as absolute activities in each frequency band (reported as
amplitude in A/D units, in which 100 units 79 µV),
Th/De as the ratio of absolute activities in each band, and EMG also as an absolute activity. Data are presented
as mean ± SEM for R, n = 8;
for NA, n = 5; for
5-HT, n = 8. *Significantly different from Ringer's, according to paired comparison
t tests (p 0.05).
|
|
Noradrenaline
On the lowering of the filled cannulae, all rats woke up and
remained awake before and during the injection of noradrenaline (75 nmol per side, n = 5; see Fig. 5). In the 30 min
postinjection period, all rats remained awake except for some brief
episodes of tSWS or SWS in some rats (2 of 5). EEG frequency
band activities showed variable but generally moderately high activity during the postinjection period, which reached levels present
during active waking or PS during the preinjection recording period in all rats. remained low during the postinjection recording period in
all rats. The animals manifested normal waking behaviors, which included Wattentive (standing motionless with body and head
erect) or Wmoving (moving or walking about the cage) but
also occasionally Wquiet (recumbent with eyes open).
Across animals, the wake state was increased significantly (to an
average of >95% of recording time), tSWS and SWS were
decreased significantly, and PS and tPS were absent during
the postinjection recording period after noradrenaline (Fig. 7). There
was a significant increase in average activity and a significant
decrease in average activity, as compared with those after
Ringer's during this period (Fig. 8). The average EMG activity was
higher than that after Ringer's, although not significantly so
(p = 0.08).
The EEG during the postinjection period after noradrenaline was
characterized by a low-voltage fast pattern (Fig.
9), which is normally characteristic of
the wake state. In the high-frequency filtered record, relatively high
amplitude activity was apparent. In average spectra of epochs
during the postinjection period, a small peak was evident in the band, which is normally the case during waking attentive or active
behaviors in the rat (Maloney et al., 1997 ). Although no distinct peak
was present in the high-frequency portion of the spectra, the amplitude
in the band was relatively high, as also has been found to be the
case during attentive or active waking behaviors (Maloney et al.,
1997 ). The wake state after noradrenaline when compared with that after
Ringer's had significantly higher relative activity (Table
1). The EMG was also higher during wake
after noradrenaline, although not significantly so (Table 1;
p = 0.07).

View larger version (44K):
[in this window]
[in a new window]
|
Figure 9.
EEG samples from noradrenaline and serotonin
postinjection recording periods. Shown are unfiltered
(top) and high-frequency (30.5-58.0 Hz) filtered
(bottom) EEG samples (2 sec each) illustrating EEG
patterns that occurred during the respective postinjection recording
periods. Noradrenaline produced a low-voltage fast EEG pattern
(top) in association with relatively high activity
(bottom), similar to normal wake (rat B10), whereas
serotonin produced a high-voltage slow EEG pattern (top)
in association with relatively low activity
(bottom), similar to normal SWS (rat B20). The samples
were taken ~2-3 min after the injection was stopped. The EEG was
recorded by reference to an electrode in the rostral frontal bone from
the left and right frontal (LF and
RF), retrosplenial (LRS and
RRS), parietal (LP and
RP), and occipital (RO) cortical regions.
Voltage scales are the same for all cortical leads.
|
|
View this table:
[in this window]
[in a new window]
|
Table 1.
Relative and activity, ratio of Th/De activities,
and EMG amplitude during the postinjection total period or wake and SWS
states after noradrenaline and serotonin as compared with Ringer'sa
|
|
Serotonin
As was the case for Ringer's, all animals resumed sleeping after
the filled cannulae were lowered or the injection was started with
serotonin (250 nmol per side, n = 8; see Fig. 6). SWS
occurred in all rats in the 30 min postinjection period. PS occurred in only one rat (of eight) during this same time period. In EEG activity, serotonin microinjections were associated with an apparent decrease in
activity (8 of 8 rats) through most of the postinjection period
(see Fig. 6). activity could be relatively high during this period,
reaching levels apparently equal to or higher than those present during
SWS in the preinjection recording period. The Th/De ratio remained low.
During these episodes of high , two behavioral states were observed:
sleeping or quiet waking. During sleeping behavior (marked by eyes
closed), high activity usually was associated with a normal sleep
posture and behavior (Scurled or more often
Suncurled), although in one rat it was associated with an
abnormal outstretched posture. All of these epochs were scored as SWS
or tSWS. During waking behavior (marked by eyes open) the
activity, which appeared to be of lower amplitude than that during
sleeping behavior, was associated with quiet behavior (usually
recumbent, noted as Wquiet, although also occasionally moving during positional shifts, noted as Wmoving). This
apparent dissociation between EEG activity and waking behavior was
seen in one-half of the rats. These epochs were scored as the wake state, according to the behavioral notation and despite the presence of
EEG activity. During both the SWS and wake episodes in many rats,
the EMG activity appeared relatively high as compared with the
preinjection levels.
During the postinjection recording period after serotonin, the average
percentage of the wake state did not differ significantly from that
after Ringer's, although it did appear to be higher (see Fig. 7).
Similarly, the average amount of slow wave sleep (tSWS and
SWS) was not changed significantly (representing >55%). On the other
hand, average tPS and PS were decreased significantly (to
<3%). Across animals, the EEG was altered during the postinjection period by significantly lower average activity, as compared with
Ringer's (see Fig. 8). The ratio of Th/De was also significantly lower
than that with Ringer's (which in turn was significantly lower than
that in baseline, above). EMG amplitude was significantly higher after
serotonin than after Ringer's.
The EEG during the postinjection period after serotonin often was
characterized by high-voltage slow waves with relatively low amplitude
activity (Fig. 9), thereby resembling that of SWS. The average
spectra for epochs sampled during this period revealed a large peak in
the band (Fig. 10), which is
typical of natural SWS. The EEG of SWS epochs, as compared with those of Ringer's, had significantly higher relative activity and lower
Th/De ratio (see Table 1). The EMG activity was also higher than that
in normal SWS epochs, although not significantly so. The postserotonin
wake epochs, which include the anomalous wake episodes (above), also
differed from those after Ringer's by significantly lower relative
, higher relative , lower Th/De, and higher EMG activities (see
Table 1).

View larger version (12K):
[in this window]
[in a new window]
|
Figure 10.
Average spectra from epochs after the injection
of noradrenaline (rat B10) and serotonin (rat B20). After
noradrenaline, a small low-frequency peak is in the range, and the
overall amplitude in the range is relatively high. After serotonin,
a prominent peak is evident in the band, and a relatively low
overall amplitude is evident in the band. The spectra were computed
from five 4 sec EEG segments from the right retrosplenial lead that
were each 1 min apart and occurred within ~2-8 min after the
injection. Spectra are displayed in amplitude (A/D units, in which
100 79 µV) per 0.5 Hz shown at different scales for the
low-frequency range (1.5-18.5 Hz) and the high-frequency range
(19.0-58.0 Hz) to maximize the appearance of potential peaks in each
range. , , and frequency bands, which were used for
calculating total activity per band (see Figs. 2-6, 8, 11), are
shaded differentially.
|
|
Dose-response relationships
The differential effects of noradrenaline and serotonin on
-EEG activity were found to be dose-dependent (Fig.
11). Whereas increasing doses of
noradrenaline were associated with increases in average during the
postinjection period, increasing doses of serotonin were associated
with decreases in average , each reaching a plateau at the maximum
dose used in the main study. Noradrenaline also was associated with a
dose-dependent decrease in activity. With regard to state, the
increase in wake and decrease in SWS produced by noradrenaline were
significantly dependent on dose (with ANCOVA, df = 4, 1;
p 0.05; data not shown). Serotonin had no
significant dose-dependent effect on activity or on wake or SWS
states. On the other hand, the decreases in PS after noradrenaline and
serotonin were both significantly dose-dependent (with
ANCOVA, df = 4, 1; p 0.05; data not
shown).

View larger version (12K):
[in this window]
[in a new window]
|
Figure 11.
Dose-response relationships showing the effect
of increasing doses of noradrenaline and serotonin on average EEG
frequency band activity during the postinjection period (see Fig. 8).
Least-squares means plots are presented from the output of ANCOVAs
(with dose as the main factor and rat as the covariate). EEG activities
are taken from the right retrosplenial lead and reported as amplitude in A/D units, in which 100 units 79 µV, or are reported as a ratio. Dose indicates total nanomoles of drug injected
on each side, and 0 corresponds to Ringer's.
*Significant main effect of dose for NA
(n = 4) or 5-HT
(n = 3) (ANCOVA, df = 4, 1;
p 0.05).
|
|
 |
DISCUSSION |
The results of the present study demonstrate that noradrenaline
and serotonin, which have been shown in vitro to exert
respective depolarizing versus hyperpolarizing influences on
cholinergic basalis neurons (Khateb et al., 1993 ; Fort et al., 1995 ),
produce differential effects on EEG activity and sleep-wake state when microinjected in vivo into the region of the cholinergic
basalis neurons. Whereas noradrenaline facilitated activity and
elicited waking, serotonin diminished high-frequency activity and
did not affect slow wave sleep significantly in the naturally
sleeping-waking rat during the day when the animals are normally
asleep the majority of the time. On the other hand, both
neurotransmitters eliminated paradoxical sleep.
Noradrenaline facilitates -EEG activity and elicits waking
Noradrenaline microinjections into the basal forebrain produced a
significant and dose-dependent increase in activity and a
reciprocal decrease in activity, associated with an increase in the
wake state. This effect on EEG activity is interpreted as being
attributable to the depolarization and excitation of the cholinergic
basalis neurons by noradrenaline that have been demonstrated in
vitro (Fort et al., 1995 ). Driven into a tonic mode of firing, the
cholinergic basalis neurons could be expected to exert a tonic
facilitatory influence on cortical neurons and activity that would be
evident as a decrease in low-frequency burst firing and an increase in
high-frequency tonic firing by the cortical neurons (Krnjevic, 1967 ;
McCormick, 1992 ; Metherate et al., 1992 ). At the level of EEG activity,
these changes would underlie a shift from to activity during
the period of the day when the animals are normally asleep. It also
must be considered that noradrenaline additionally exerts its effects
through the basal forebrain via noncholinergic, putative cortically
projecting cells, the vast majority of which also are depolarized and
excited by noradrenaline (Fort et al., 1992 , 1998 ). In the present
study the EEG changes were associated with the intrusion of the wake state into diurnal sleep and, moreover, the stimulation of a relatively aroused state of waking, marked by a higher relative amount of activity, which is associated with attentive or active waking behaviors
(Maloney et al., 1997 ).
An important role of noradrenergic locus coeruleus neurons in the
facilitation of cortical activation and waking has been recognized for
many years (see Jouvet, 1972 ; Jones et al., 1973 ). Although studies
have shown that these neurons are not essential for the maintenance of
these activities (see Jones et al., 1977 ; Jones, 1991 ), multiple
pharmacological and physiological studies have demonstrated that the
noradrenergic locus coeruleus neurons normally have the capacity to
facilitate and prolong cortical activation and waking (see Jacobs and
Jones, 1978 ). They discharge at the highest rate during active and
attentive waking and decrease their rate of firing during quiet waking
and slow wave sleep (Aston-Jones and Bloom, 1981a ; Rasmussen et al.,
1986 ). They also increase their rate of firing transiently in
association with responses to sensory stimuli, including orientation
(Aston-Jones and Bloom, 1981b ; Rasmussen et al., 1986 ). Accordingly,
they would be expected to exert a facilitatory influence on cholinergic
basalis neurons in association with sensory stimulation and orientation
that would, in turn, facilitate cortical activation (Metherate et al.,
1992 ). It has been found that stimulation of the locus coeruleus
generates cortical activation with a shift from low-frequency to higher frequency EEG activity (Berridge and Foote, 1991 ) and that lesions of
noradrenergic fibers are associated with a loss of high-frequency EEG
activity in response to sensory stimuli (Delagrange et al., 1989 ). The
present results suggest that noradrenaline can facilitate high-frequency activity and waking by acting on cholinergic basalis
neurons in addition to acting on thalamic and cortical systems
(McCormick, 1992 ).
The noradrenaline microinjections into the basal forebrain also
resulted in a suppression of PS, which can be interpreted simply as
attributable to the facilitation of waking but possibly also to a
general opposing role of noradrenaline in the generation of this state
(Hobson et al., 1975 ; Aston-Jones and Bloom, 1981a ).
Serotonin diminishes -EEG activity and allows SWS
Serotonin produced a significant and dose-dependent decrease in
high-frequency and did not increase waking or decrease slow wave
sleep significantly during the daytime recording period when rats are
naturally asleep the majority of the time. This EEG effect could be
interpreted as being attributable to the hyperpolarization and
inhibition of cholinergic basalis neurons by serotonin (Khateb et al.,
1993 ). It is additionally possible that the effect could be
attributable to the action of serotonin on noncholinergic, putative
cortically projecting basalis neurons, the majority of which also are
hyperpolarized and inhibited by serotonin (Fort et al., 1992 , 1998 ). It
is presumed that by its action on cortically projecting cells,
serotonin diminishes cortical activation, as evidenced by decreased activity, and accordingly is associated with a quiet waking state or
slow wave sleep during the day when the animal is naturally asleep.
The role of serotonin in sleep-wake states has been debated
greatly over the past 25 years. The demonstration that lesions of the
serotonergic raphe neurons could result in complete insomnia originally
led Jouvet to propose that serotonergic neurons play a determining role
in the generation of slow wave sleep (for review, see Jouvet, 1972 ). In
support of this theory, depletion of serotonin by the inhibition of
tryptophan hydroxylase with para-chlorophenylalanine (PCPA) also was
shown in the cat to produce insomnia, which could be reversed
by subsequent peripheral or central administration of low doses of
5-hydroxytryptophan (5-HTP), the immediate precursor of serotonin
(Denoyer et al., 1989 ) (for review, see Jouvet, 1972 ). However,
subsequent studies, particularly in rats, indicated that serotonin was
not necessary for the appearance of slow wave sleep, although it could
facilitate the onset of sleep (for review, see Jacobs and Jones, 1978 ;
Jacobs and Fornal, 1991 ; Jones, 1994 ). Moreover, dorsal raphe neurons
were found to discharge at their highest rates during waking and
decrease their firing rate (by ~50%) during slow wave sleep,
indicating that they likely did not generate slow wave sleep (McGinty
and Harper, 1976 ; Trulson and Jacobs, 1979 ) (for review, see
Jacobs and Fornal, 1991 ). On the other hand, their higher
discharge rate during waking could be associated specifically with
suppression of particular waking behaviors and responses to inputs that
can interfere with sleep onset (McGinty and Harper, 1976 ; Trulson and
Jacobs, 1979 ). In fact, it has been found that, on presentation of
sensory stimuli (Aghajanian et al., 1978 ) and during orientation to
stimuli (Jacobs and Fornal, 1991 ), many putative serotonergic raphe
units cease firing (in contrast to the noradrenergic locus coeruleus
neurons, which increase firing). According to the in vitro
results (Khateb et al., 1993 ), this cessation of serotonergic neuronal
discharge could be associated with a disinhibition of the cholinergic
basalis neurons during the cortical activation that occurs with sensory stimulation and orientation. Conversely, discharge by the serotonergic neurons under other circumstances would hyperpolarize the cholinergic cells and prevent their tonic discharge, which in turn could be associated with a decrease in cortical activation, like that which we
have measured here as a decrease in -EEG activity after
microinjections of serotonin. In accordance with this interpretation,
the dorsal raphe neurons have been found to discharge at higher rates
during grooming behavior (Fornal et al., 1996 ), when cortical activity is low (Maloney et al., 1997 ), than during attentive behavior, when cortical activity is high. A cortical "deactivation"
produced by the action of serotonin on cholinergic basalis neurons thus could be associated with relaxed or quiet waking or with slow wave
sleep during the diurnal, maximal sleep period of the day.
Despite the continuity of slow wave sleep after serotonin
microinjections, the resulting sleep and sleep cycle were not
completely normal but were marked by higher EMG activity and the
absence of paradoxical sleep as well as diminished activity, which
marks that state in cortical, as well hippocampal, EEG (Maloney et al., 1997 ). The results of the effects of serotonin in the basal forebrain concur with results showing a facilitatory role of serotonin through other areas of the CNS on muscle tonus and certain rhythmic motor behaviors and a suppressive role of serotonin in paradoxical sleep and
activity (for review, see Steriade and Hobson, 1976 ; Jacobs and
Fornal, 1991 ; Holmes and Jones, 1994 ; Vertes et al., 1994 ; Fornal et
al., 1996 ). The partial dissociation between EEG activity and behavior
seen in some rats after serotonin microinjections in the present study
is also well known to occur after systemic injections of atropine,
which, by blocking cholinergic muscarinic receptors, results in a
pattern of slow wave EEG activity during a behaviorally awake state
(Longo, 1966 ; Stewart et al., 1984 ). Our results show that serotonin
microinjections into the basal forebrain similarly may result in slow
waves in the cerebral cortex, thought to be attributable in this case
to the inhibition of cholinergic basalis neurons, but not necessarily
in a decrease in muscle tone that normally occurs during slow wave
sleep and precedes paradoxical sleep. The results also suggest that
serotonin may act on other noncholinergic neurons in the area that, via
descending projections, may be involved in movement and maintenance of
muscle tone (Swanson et al., 1984 ), which can persist during slow wave
sleep, but not during paradoxical sleep.
Conclusions
When injected into the basal forebrain of a naturally
sleeping-waking rat during the day, noradrenaline, which is known to depolarize cholinergic neurons, diminishes activity and slow wave
sleep and stimulates high-frequency -EEG activity and waking. In
contrast, serotonin, which is known to hyperpolarize cholinergic basalis neurons, diminishes high-frequency -EEG activity and has no
decremental effect on activity or slow wave sleep. It is concluded
that noradrenaline and serotonin may play differential roles in
modulating cortical activity in part via their opposing actions on
cholinergic basalis neurons, which in turn have been shown to play an
important role in facilitating high-frequency -EEG activity and
waking.
 |
FOOTNOTES |
Received Sept. 15, 1997; revised Jan. 6, 1998; accepted Jan. 8, 1998.
This research was supported by a grant to B.E.J. from the Canadian
Medical Research Council. E.G.C. was supported as a graduate student by
the Fonds de Recherche en Santé du Québec, Reseau de
Santé Mentale, Axe Sommeil et Vigilance. We thank Lynda Mainville for her technical assistance and Jean Gotman, Angel Alonso, and Michel
Muhlethaler for their helpful consultation.
Correspondence should be addressed to Dr. Barbara E. Jones,
Montréal Neurological Institute, 3801 University Street,
Montréal, Québec H3A 2B4, Canada.
 |
REFERENCES |
-
Aghajanian GK,
Wang RY,
Barban J
(1978)
Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation.
Brain Res
153:169-175[Web of Science][Medline].
-
Aston-Jones G,
Bloom FE
(1981a)
Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle.
J Neurosci
1:876-886[Abstract].
-
Aston-Jones G,
Bloom FE
(1981b)
Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli.
J Neurosci
1:887-900[Abstract].
-
Berridge CW,
Foote SL
(1991)
Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus.
J Neurosci
11:3135-3145[Abstract].
-
Buzsáki G,
Bickford RG,
Ponomareff G,
Thal LJ,
Mandel R,
Gage FH
(1988)
Nucleus basalis and thalamic control of neocortical activity in the freely moving rat.
J Neurosci
8:4007-4026[Abstract].
-
Cape E,
Jones BE
(1994)
Modulation of sleep-wake state and cortical activity following injection of agonists into the region of cholinergic basal forebrain neurons.
Soc Neurosci Abstr
20:156.
-
Casamenti F,
Deffenu G,
Abbamondi AL,
Pepeu G
(1986)
Changes in cortical acetylcholine output induced by modulation of the nucleus basalis.
Brain Res Bull
16:689-695[Web of Science][Medline].
-
Celesia GG,
Jasper HH
(1966)
Acetylcholine released from cerebral cortex in relation to state of activation.
Neurology
16:1053-1064[Free Full Text].
-
Delagrange P,
Tadjer D,
Bouyer J-J,
Rougeul A,
Conrath M
(1989)
Effect of DSP4, a neurotoxic agent, on attentive behaviour and related electrocortical activity in cat.
Behav Brain Res
33:33-43[Web of Science][Medline].
-
Denoyer M,
Sallanon M,
Kitahama K,
Aubert C,
Jouvet M
(1989)
Reversibility of para-chlorophenylalanine-induced insomnia by intrahypothalamic microinjection of L-5-hydroxytryptophan.
Neuroscience
28:83-94[Web of Science][Medline].
-
Fornal CA,
Metzler CW,
Marrosu F,
Ribiero-do-Valle LE,
Jacobs BL
(1996)
A subgroup of dorsal raphe serotonergic neurons in the cat is strongly activated during oral-buccal movements.
Brain Res
716:123-133[Web of Science][Medline].
-
Fort P,
Khateb A,
Alonso A,
Jones BE,
Muhlethaler M
(1992)
Pharmacological heterogeneity of basal forebrain neurones.
Soc Neurosci Abstr
18:881.
-
Fort P,
Khateb A,
Pegna A,
Muhlethaler M,
Jones BE
(1995)
Noradrenergic modulation of cholinergic nucleus basalis neurons demonstrated by in vitro pharmacological and immunohistochemical evidence in the guinea pig brain.
Eur J Neurosci
7:1502-1511[Web of Science][Medline].
-
Fort P,
Khateb A,
Serafin M,
Muhlethaler M,
Jones BE
(1998)
Pharmacological characterization and differentiation of non-cholinergic nucleus basalis neurons in vitro.
NeuroReport
9:61-65[Web of Science][Medline].
-
Gritti I,
Mainville L,
Jones BE
(1993)
Codistribution of GABA- with acetylcholine-synthesizing neurons in the basal forebrain of the rat.
J Comp Neurol
329:438-457[Web of Science][Medline].
-
Hobson JA,
McCarley RW,
Wyzinski PW
(1975)
Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups.
Science
189:55-58.
-
Holmes CJ,
Jones BE
(1994)
Importance of cholinergic, GABAergic, serotonergic, and other neurons in the medullary reticular formation for sleep-wake states studied by cytotoxic lesions in the cat.
Neuroscience
62:1179-1200[Web of Science][Medline].
-
Jacobs BL,
Fornal CA
(1991)
Activity of brain serotonergic neurons in the behaving animal.
Pharmacol Rev
43:563-578[Web of Science][Medline].
-
Jacobs BL,
Jones BE
(1978)
The role of central monoamine and acetylcholine systems in sleep-wakefulness states: mediation or modulation.
In: Cholinergic-monoaminergic interactions in the brain (Butcher LL,
ed), pp 271-290. New York: Academic.
-
Jasper HH,
Tessier J
(1971)
Acetylcholine liberation from cerebral cortex during paradoxical (REM) sleep.
Science
172:601-602[Abstract/Free Full Text].
-
Jones BE
(1991)
The role of noradrenergic locus coeruleus neurons and neighboring cholinergic neurons of the pontomesencephalic tegmentum in sleep-wake states.
In: Neurobiology of the locus coeruleus. Progress in brain research, Vol 85 (Barnes C,
Pompeiano O,
eds), pp 532-543. Amsterdam: Elsevier.
-
Jones BE
(1993)
The organization of central cholinergic systems and their functional importance in sleep-waking states.
In: Cholinergic function and dysfunction. Progress in brain research, Vol 98 (Cuello AC,
ed), pp 61-71. Amsterdam: Elsevier.
-
Jones BE
(1994)
Basic mechanisms of sleep-wake states.
In: Principles and practice of sleep medicine, 2nd Ed (Kryger MH,
Roth T,
Dement WC,
eds), pp 145-162. Philadelphia: Saunders.
-
Jones BE
(1995)
Reticular formation. Cytoarchitecture, transmitters, and projections.
In: The rat nervous system, 2nd Ed (Paxinos G,
ed), pp 155-171. New South Wales, Australia: Academic.
-
Jones BE,
Beaudet A
(1987)
Retrograde labeling of neurons in the brain stem following injections of [3H]choline into the forebrain of the rat.
Exp Brain Res
65:437-448[Web of Science][Medline].
-
Jones BE,
Cuello AC
(1989)
Afferents to the basal forebrain cholinergic cell area from pontomesencephalic
catecholamine, serotonin, and acetylcholine neurons.
Neuroscience
31:37-61[Web of Science][Medline]. -
Jones BE,
Yang T-Z
(1985)
The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat.
J Comp Neurol
242:56-92[Web of Science][Medline].
-
Jones BE,
Bobillier P,
Pin C,
Jouvet M
(1973)
The effect of lesions of catecholamine-containing neurons upon monoamine content of the brain and EEG and behavioral waking in the cat.
Brain Res
58:157-177[Web of Science][Medline].
-
Jones BE,
Harper ST,
Halaris AE
(1977)
Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine.
Brain Res
124:473-496[Web of Science][Medline].
-
Jouvet M
(1972)
The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle.
Ergeb Physiol
64:165-307.
-
Khateb A,
Muhlethaler M,
Alonso A,
Serafin M,
Mainville L,
Jones BE
(1992)
Cholinergic nucleus basalis neurons display the capacity for rhythmic bursting activity mediated by low threshold calcium spikes.
Neuroscience
51:489-494[Web of Science][Medline].
-
Khateb A,
Fort P,
Alonso A,
Jones BE,
Muhlethaler M
(1993)
Pharmacological and immunohistochemical evidence for a serotonergic input to cholinergic nucleus basalis neurons.
Eur J Neurosci
5:541-547[Web of Science][Medline].
-
Krnjevic K
(1967)
Chemical transmission and cortical arousal.
Anesthesiology
28:100-104[Web of Science][Medline].
-
Lehmann J,
Nagy JI,
Atmadja S,
Fibiger HC
(1980)
The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat.
Neuroscience
5:1161-1174[Web of Science][Medline].
-
Lo Conte G,
Casamenti F,
Bigl V,
Milaneschi E,
Pepeu G
(1982)
Effect of magnocellular forebrain nuclei lesions on acetylcholine output from the cerebral cortex, electrocorticogram, and behaviour.
Arch Ital Biol
120:176-188[Web of Science][Medline].
-
Longo VG
(1966)
Behavioral and electroencephalographic effects of atropine and related compounds.
Pharmacol Rev
18:965-996[Free Full Text].
-
Maloney KJ,
Cape EG,
Gotman J,
Jones BE
(1997)
High frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat.
Neuroscience
76:541-555[Web of Science][Medline].
-
Martin JH
(1991)
Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat.
Neurosci Lett
127:160-164[Web of Science][Medline].
-
McCormick DA
(1992)
Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity.
Prog Neurobiol
39:337-388[Web of Science][Medline].
-
McGinty D,
Harper RM
(1976)
Dorsal raphe neurons: depression of firing during sleep in cats.
Brain Res
101:569-575[Web of Science][Medline].
-
Metherate R,
Cox CL,
Ashe JH
(1992)
Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine.
J Neurosci
12:4701-4711[Abstract].
-
Moruzzi G,
Magoun HW
(1949)
Brainstem reticular formation and activation of the EEG.
Electroencephalogr Clin Neurophysiol
1:455-473[Web of Science][Medline].
-
Myers RD
(1974)
In: Handbook of drug and chemical stimulation of the brain. New York: Van Nostrand Reinhold.
-
Rasmusson DD,
Clow K,
Szerb JC
(1994)
Modification of neocortical acetylcholine release and electroencephalogram desynchronization due to brainstem stimulation by drugs applied to the basal forebrain.
Neuroscience
60:665-677[Web of Science][Medline].
-
Rasmussen K,
Morilak DA,
Jacobs BL
(1986)
Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli.
Brain Res
371:324-334[Web of Science][Medline].
-
Rye DB,
Wainer BH,
Mesulam M-M,
Mufson EJ,
Saper CB
(1984)
Cortical projections arising from the basal forebrain: a study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase.
Neuroscience
13:627-643[Web of Science][Medline].
-
Semba K,
Reiner PB,
McGeer EG,
Fibiger HC
(1988)
Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat.
J Comp Neurol
267:433-453[Web of Science][Medline].
-
Shute CCD,
Lewis PR
(1967)
The ascending cholinergic reticular system: neocortical, olfactory, and subcortical projections.
Brain
90:497-520[Free Full Text].
-
Starzl TE,
Taylor CW,
Magoun HW
(1951)
Ascending conduction in reticular activating system, with special reference to the diencephalon.
J Neurophysiol
14:461-477[Free Full Text].
-
Steriade M,
Hobson JA
(1976)
Neuronal activity during the sleep-waking cycle.
Prog Neurobiol
6:155-376[Medline].
-
Stewart DJ,
Macfabe DF,
Vanderwolf CH
(1984)
Cholinergic activation of the electrocorticogram: role of the substantia innominata and effects of atropine and quinuclidinyl benzilate.
Brain Res
322:219-232[Web of Science][Medline].
-
Swanson LW,
Mogenson GJ,
Gerfen CR,
Robinson P
(1984)
Evidence for a projection from the lateral preoptic area and substantia innominata to the "mesencephalic locomotor region" in the rat.
Brain Res
295:161-178[Web of Science][Medline].
-
Trulson ME,
Jacobs BL
(1979)
Raphe unit activity in freely moving cats: correlation with level of behavioral arousal.
Brain Res
163:135-150[Web of Science][Medline].
-
Vergnes M,
Marescaux C,
Micheletti G,
Reis J,
Depaulis A,
Rumbach L,
Warter JM
(1982)
Spontaneous paroxysmal electroclinical patterns in rat: a model of generalized non-convulsive epilepsy.
Neurosci Lett
33:97-101[Web of Science][Medline].
-
Vertes RP,
Kinney GG,
Kocsis B,
Fortin WJ
(1994)
Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat.
Neuroscience
60:441-451[Web of Science][Medline].
-
Wenk GL
(1984)
Pharmacological manipulations of the substantia innominata-cortical cholinergic pathway.
Neurosci Lett
51:99-103[Web of Science][Medline].
Copyright © 1998 Society for Neuroscience 0270-6474/98/1872653-14$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
P. C. Zee
Sleep and Wake Neuroscience
ACCP Sleep Med Brd Rev,
January 1, 2009;
4(0):
153 - 162.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fingelkurts, S. Kahkonen, A. Fingelkurts, R. Kivisaari, S. Borisov, V. Puuskari, O. Jokela, and T. Autti
Reorganization of the composition of brain oscillations and their temporal characteristics during opioid withdrawal
J Psychopharmacol,
May 1, 2008;
22(3):
270 - 284.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Borgers, S. Epstein, and N. J. Kopell
Background gamma rhythmicity and attention in cortical local circuits: A computational study
PNAS,
May 10, 2005;
102(19):
7002 - 7007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ouyang, K. Hellman, T. Abel, and S. A. Thomas
Adrenergic Signaling Plays a Critical Role in the Maintenance of Waking and in the Regulation of REM Sleep
J Neurophysiol,
October 1, 2004;
92(4):
2071 - 2082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Lee, I. D. Manns, A. Alonso, and B. E. Jones
Sleep-Wake Related Discharge Properties of Basal Forebrain Neurons Recorded With Micropipettes in Head-Fixed Rats
J Neurophysiol,
August 1, 2004;
92(2):
1182 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Dickson, G. Biella, and M. de Curtis
Slow Periodic Events and Their Transition to Gamma Oscillations in the Entorhinal Cortex of the Isolated Guinea Pig Brain
J Neurophysiol,
July 1, 2003;
90(1):
39 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cirelli
Functional Genomics of Sleep and Circadian Rhythm: Invited Review: How sleep deprivation affects gene expression in the brain: a review of recent findings
J Appl Physiol,
January 1, 2002;
92(1):
394 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cirelli and G. Tononi
Differential Expression of Plasticity-Related Genes in Waking and Sleep and Their Regulation by the Noradrenergic System
J. Neurosci.,
December 15, 2000;
20(24):
9187 - 9194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. G. Cape, I. D. Manns, A. Alonso, A. Beaudet, and B. E. Jones
Neurotensin-Induced Bursting of Cholinergic Basal Forebrain Neurons Promotes gamma and theta Cortical Activity Together with Waking and Paradoxical Sleep
J. Neurosci.,
November 15, 2000;
20(22):
8452 - 8461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Dickson, G. Biella, and M. de Curtis
Evidence for Spatial Modules Mediated by Temporal Synchronization of Carbachol-Induced Gamma Rhythm in Medial Entorhinal Cortex
J. Neurosci.,
October 15, 2000;
20(20):
7846 - 7854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chabaud, N. Ravel, D.A. Wilson, A.M. Mouly, M. Vigouroux, V. Farget, and R. Gervais
Exposure to Behaviourally Relevant Odour Reveals Differential Characteristics in Rat Central Olfactory Pathways as Studied through Oscillatory Activities
Chem Senses,
October 1, 2000;
25(5):
561 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Manns, A. Alonso, and B. E. Jones
Discharge Properties of Juxtacellularly Labeled and Immunohistochemically Identified Cholinergic Basal Forebrain Neurons Recorded in Association with the Electroencephalogram in Anesthetized Rats
J. Neurosci.,
February 15, 2000;
20(4):
1505 - 1518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. van der Linden, F. Panzica, and M. de Curtis
Carbachol Induces Fast Oscillations in the Medial but not in the Lateral Entorhinal Cortex of the Isolated Guinea Pig Brain
J Neurophysiol,
November 1, 1999;
82(5):
2441 - 2450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Boutrel, B. Franc, R. Hen, M. Hamon, and J. Adrien
Key Role of 5-HT1B Receptors in the Regulation of Paradoxical Sleep as Evidenced in 5-HT1B Knock-Out Mice
J. Neurosci.,
April 15, 1999;
19(8):
3204 - 3212.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|